APOGEE THERAPEUTICS, INC. COMMON STOCK reports a Return on Equity (ROE) of -21.87%.

What is APGE's dividend yield?

APOGEE THERAPEUTICS, INC. COMMON STOCK offers a dividend yield of 0.00%.

What is APGE's Deepscope Quality Score?

Deepscope rates APGE's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy APGE?

Deepscope's AI Timing Score for APGE is 96 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does APGE belong to?

APOGEE THERAPEUTICS, INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

APGE (NASDAQ) Stock Analysis | APOGEE THERAPEUTICS, INC. COMMON STOCK

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-04 | FS: 2026-03-31)

APGE

APOGEE THERAPEUTICS, INC. COMMON STOCK

US:NASDAQ STOCK Healthcare >> Biotechnology News 87

USD 90.90

6.71 (7.97%) Day Change

Watchlist Portfolio Compare Chart

0.00

D/E

-21.9%

ROE

-21.2%

ROA

0.00%

Div Yield

APOGEE THERAPEUTICS, INC. COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 90.90 Price 6.71 (7.97%) Day Change	NEWS SCORE: 87

APGE, the overall quality is not good ( Quality = 23) but the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	87
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	90.90
PBV / Sector	5.05 / 4.58
Earning Per Share	-3.93

PE / Sector	N/A / 17.10
PEG or PE/Growth / Sector	N/A / 0.52
Average 1M Daily Value	76.26 M
Average 1W Daily Value	95.69 M

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 450.23
NPM Average (%) / Sector	N/A / -1,506.33
NPM Change Average (%) / Sector	N/A / 4,941.30
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-21.23 / 30.58
ROA Average (%) / Sector	-23.96 / -347.17
ROA Change Average (%) / Sector	-3.45 / 5,125.52
ROE (%) / Sector	-21.87 / -3.58
ROE Average (%) / Sector	-25.14 / 40.65
ROE Change Average (%) / Sector	-4.37 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.50
Dividend Change Average (%) / Sector	N/A / 5.02

Registration Details

Analyze Date	2026-06-05 09:12:39
Symbol	APGE
Name	APOGEE THERAPEUTICS, INC. COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	61.90 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	6,347.03 / 8,655.90

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Building 17, Waltham, MA, United States, 02453

Phone: 650 394 5230

Website: https://www.apogeetherapeutics.com

Employees: 261

Sector: Healthcare >> Biotechnology

Description: Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States. The company develops Zumilokibart (APG777), a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of atopic dermatitis, which is in phase 2 clinical trials; and for the treatment of asthma and eosinophilic esophagitis which is in phase 1 clinical trial. It also develops APG279 which is in phase 1 clinical trial for the treatment of atopic dermatitis; APG273 which is in phase 1 clinical trial for the treatment of asthma and chronic obstructive pulmonary disease; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.